Ryan Nashs Stock Ratings - Goldman Sachs Analyst - Benzinga
CANQF Stock | USD 0.03 0.01 27.81% |
Roughly 60% of CanaQuest Medical's investor base is looking to short. The analysis of overall sentiment of trading CanaQuest Medical Corp pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with CanaQuest Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use CanaQuest Medical Corp stock news signals to limit their universe of possible portfolio assets.
CanaQuest Medical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CanaQuest daily returns and investor perception about the current price of CanaQuest Medical Corp as well as its diversification or hedging effects on your existing portfolios.
CanaQuest |
Ryan Nashs Stock Ratings - Goldman Sachs Analyst Benzinga
Read at news.google.com
CanaQuest Medical Fundamental Analysis
We analyze CanaQuest Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CanaQuest Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CanaQuest Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
CanaQuest Medical is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Peers
Trending Equities
Complementary Tools for CanaQuest Pink Sheet analysis
When running CanaQuest Medical's price analysis, check to measure CanaQuest Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanaQuest Medical is operating at the current time. Most of CanaQuest Medical's value examination focuses on studying past and present price action to predict the probability of CanaQuest Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanaQuest Medical's price. Additionally, you may evaluate how the addition of CanaQuest Medical to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |